Mark Baldry - Chief Commercial Officer at X4 Pharmaceuticals, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
XFOR on Nasdaq, XFOWW on OTC
All Insider Reports
All Insider Reports

Mark Baldry - trading volume in the past year for X4 Pharmaceuticals, Inc

Holdings reported by Mark Baldry for X4 Pharmaceuticals, Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48.5K $28.4K $0.58 Oct 7, 2024 Direct
Stock Appreciation Right 523K Feb 13, 2024 Direct Common Stock

Transactions reported by Mark Baldry for X4 Pharmaceuticals, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.